- Home
- BMRN vs CHYM Comparison
BMRN vs CHYM Comparison
Compare BMRN & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | CHYM |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 12.4B |
| IPO Year | 1999 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BMRN | CHYM |
|---|---|---|
| Price | $64.61 | $34.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 19 |
| Target Price | ★ $88.22 | $31.94 |
| AVG Volume (30 Days) | 1.9M | ★ 7.0M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.77 | 0.20 |
| Revenue | $1,313,646,000.00 | ★ $2,186,770,000.00 |
| Revenue This Year | $15.02 | $23.65 |
| Revenue Next Year | $12.23 | $19.12 |
| P/E Ratio | ★ $83.94 | $161.55 |
| Revenue Growth | 17.62 | ★ 30.69 |
| 52 Week Low | $49.26 | $15.88 |
| 52 Week High | $70.98 | $34.44 |
Technical Indicators
Market Signals| Indicator | BMRN | CHYM |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 65.82 |
| Support Level | $64.07 | $30.38 |
| Resistance Level | $66.28 | N/A |
| Average True Range (ATR) | 1.59 | 1.30 |
| MACD | -0.42 | -0.31 |
| Stochastic Oscillator | 21.14 | 71.71 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About CHYM Chime Financial Inc.
Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.